Bambec Tablets 10mg & 20mg
Last Updated on eMC 12-Jun-2017 View document | AstraZeneca UK Limited Contact details
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 12-Jun-2017 and displayed until Current
Reasons for adding or updating:
- Change to section 5 - how to store or dispose
- Change to section 6 - date of revision
- Improved presentation of PIL
Updated on 21-Jun-2016 and displayed until 12-Jun-2017
Reasons for adding or updating:
- Change to section 1 - what the product is used for
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - pregnancy, breast feeding and fertility
- Change to section 3 - how to take/use
- Change to section 6 - date of revision
Updated on 29-Aug-2014 and displayed until 21-Jun-2016
Reasons for adding or updating:
- Change to section 1 - what the product is
- Change to section 1 - what the product is used for
- Change to section 2 - what you need to know - contraindications
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 2 - pregnancy, breast feeding and fertility
- Change to section 2 - driving and using machines
- Change to section 2 - excipient warnings
- Change to section 3 - use in children/adolescents
- Change to section 3 - how to take/use
- Change to section 3 - overdose, missed or forgotten doses
- Change to section 4 - possible side effects
- Change to section 4 - how to report a side effect
- Change to section 5 - how to store
- Change to section 6 - what the product contains
- Change to section 6 - date of revision
Updated on 23-Mar-2011 and displayed until 29-Aug-2014
Reasons for adding or updating:
- Change to date of revision
- Change to warnings or special precautions for use
- Change to side-effects
Updated on 02-Jul-2009 and displayed until 23-Mar-2011
Reasons for adding or updating:
- Change to warnings or special precautions for use
- Change to side-effects
Updated on 19-Oct-2007 and displayed until 02-Jul-2009
Reasons for adding or updating:
- Change due to user-testing of patient information
Updated on 26-Nov-2003 and displayed until 19-Oct-2007
Reasons for adding or updating:
- Update to PIL
Updated on 04-Sep-2002 and displayed until 26-Nov-2003
Reasons for adding or updating:
- Update to PIL
Updated on 17-Jun-2002 and displayed until 04-Sep-2002
Reasons for adding or updating:
- New PIL for eMC ie a PIL for an existing product but new to the eMC
AstraZeneca UK Limited
Horizon Place, 600 Capability Green, Luton, Bedfordshire, LU1 3LU
+44 (0)1582 838 000
+44 (0)1582 838 003
+44 (0)1582 836 000
0800 783 0033
+44 (0)1582 837 837
Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Active ingredients
Legal categories
This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue